ABSTRACT
Background Several studies have reported enlarged amygdala and smaller hippocampus volumes in children and adolescents exposed to maternal depression. It is unclear whether similar volumetric differences are detectable in the infants’ first weeks of life, following exposure in utero. We investigated subcortical volumes in 2-to-6 week old infants exposed to antenatal maternal depression (AMD) from a South African birth cohort.
Methods AMD was measured with the Beck Depression Inventory 2nd edition (BDI-II) at 28-32 weeks gestation. T2-weighted structural images were acquired during natural sleep on a 3T Siemens Allegra scanner. Subcortical regions were segmented based on the University of North Carolina neonatal brain atlas. Volumetric estimates were compared between AMD-exposed (BDI-II⍰20) and unexposed (BDI-II<14) infants, adjusted for age, sex and total intracranial volume using analysis of covariance.
Results Larger volumes were observed in AMD-exposed (N=49) compared to unexposed infants (N=75) for the right amygdala (1.98% difference, p=0.039) and bilateral caudate nucleus (left: 5.78% difference, p=0.001; right: 6.06% difference, p<0.001). A significant AMD-by-sex interaction was found for the hippocampus (left: F(1,118)=4.80, p=0.030; right: F(1,118)=5.16, p=0.025), reflecting greater volume in AMD-exposed females (left: 5.09% difference, p=0.001, right: 3.53% difference, p=0.010), but not males.
Conclusions Volumetric differences in subcortical regions can be detected in AMD-exposed infants soon after birth, suggesting structural changes may occur in utero. Female infants might exhibit volumetric changes that are not observed in male infants. The potential mechanisms underlying these early volumetric differences, and their significance for long-term child mental health, require further investigation.
Competing Interest Statement
DJS has received research grants and/or consultancy honoraria from Discovery Vitality, Johnson & Johnson, Lundbeck, Sanofi, Servier, Takeda and Vistagen. The authors have no other potential conflicts of interest to declare.
Funding Statement
Funding: The Drakenstein Child Health Study is funded by the Bill & Melinda Gates Foundation [OPP 1017641]. This publication was made possible in part by a grant from Carnegie Corporation of New York. HJZ, KAD and DJS received financial support from the South African Medical Research Council (SAMRC). NAG was supported by a Claude Leon Postdoctoral Fellowship. CJW was supported by the Wellcome Trust [203525/Z/16/Z]. KAD received support for neuroimaging by the Brain & Behavior Research Foundation Independent Investigator grant (24467), ABMRF young investigator grant, NIH-R21AA023887, and Harry Crossley Foundation. The study funders had no role in study design, data collection, data analysis, data interpretation, manuscript preparation and decision to submit for publication. The statements made and views expressed are solely the responsibility of the author.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Ethics Committee of the University of Cape Town, Faculty of Health Sciences gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The Drakenstein Child Health Study is committed to the principle of data sharing. Deidentified data will be made available to requesting researchers as appropriate. Requests for collaborations to undertake data analysis are welcome. More information can be found on our website [http://www.paediatrics.uct.ac.za/scah/dclhs].
